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Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA
Human respiratory syncytial virus (RSV) is a lung tropic virus causing severe
airway diseases including bronchiolitis and pneumonia among infants, children, and
immuno-compromised individuals. RSV triggers transforming growth factor-β (TGF-β)
production from lung epithelial cells and TGF-β facilitates RSV infection of these cells.
However, it is still unknown whether RSV infected myeloid cells like macrophages
produce TGF-β and the role of TGF-β if any during RSV infection of these cells. Our
study revealed that RSV infected macrophages produce TGF-β and as a consequence
these cells activate TGF-β dependent SMAD-2/3 signaling pathway. Further mechanistic
studies illustrated a role of autophagy in triggering TGF-β production from RSV infected
macrophages. In an effort to elucidate the role of TGF-β and SMAD-2/3 signaling
during RSV infection, we surprisingly unfolded the requirement of TGF-β—SMAD2/3
signaling in conferring optimal innate immune antiviral response during RSV infection
of macrophages. Type-I interferon (e.g., interferon-β or IFN-β) is a critical host factor
regulating innate immune antiviral response during RSV infection. Our study revealed
that loss of TGF-β—SMAD2/3 signaling pathway in RSV infected macrophages led to
diminished expression and production of IFN-β. Inhibiting autophagy in RSV infected
macrophages also resulted in reduced production of IFN-β. Thus, our studies have
unfolded the requirement of autophagy—TGF-β—SMAD2/3 signaling network for
optimal innate immune antiviral response during RSV infection of macrophages.
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INTRODUCTION
Human respiratory syncytial virus (RSV) causes severe lung diseases bronchiolitis and pneumonia
among high risk individuals (e.g., infants, children, immuno-compromised individuals; Hall,
2001; Falsey et al., 2005). Innate immune antiviral response mediated by type-I interferon (e.g.,
interferon-β or IFN-β) is critical for combating virus infection (Uematsu and Akira, 2007; Wilkins
and Gale, 2010; Newton and Dixit, 2012). IFN-β plays a pivotal role in host defense against RSV
infection and is a major player driving virus clearance from the respiratory tract. RSV infected cells
utilize various mechanisms including activation of pattern recognition receptors (PRRs), to trigger
IFN-β release during infection (Sabbah et al., 2009; Tsai et al., 2015). In the current study we have
unfolded a previously unknown mechanism regulating IFN-β production during RSV infection.
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We have identified a signaling network comprising of autophagy,
transforming growth factor-β (TGF-β) and TGF-β induced
SMAD-2/3 signaling in promoting IFN-β response in RSV
infected macrophages.
Our current study stemmed from our attempt to understand
the role of TGF-β in RSV infected macrophages. Previous
studies have demonstrated TGF-β production from RSV infected
lung epithelial cells (McCann and Imani, 2007; Gibbs et al.,
2009; Mgbemena et al., 2011; Bakre et al., 2015). Epithelial cell
specific TGF-β facilitated RSV infection of lung epithelial cells
(McCann and Imani, 2007; Gibbs et al., 2009; Mgbemena et al.,
2011). In addition, TGF-β regulated immune response in RSV
infected neonatal dendritic cell-T cell co-culture (Thornburg
et al., 2010). However, so far no studies have focused on the role
of TGF-β induced SMAD-2/3 signaling during RSV infection.
Recent studies have unfolded a “pivotal” role of myeloid cells
like macrophages in regulating innate immunity and virus
pathogenesis during respiratory virus infection (Peschke et al.,
1993; Gordon and Read, 2002; Schneberger et al., 2011; Gwyer
Findlay and Hussell, 2012; Aggarwal et al., 2014). In that regard,
several aspect of TGF-β’s function during RSV infection has yet
to be investigated. It is unknown whether—(a) RSV infected
macrophages produce TGF-β; (b) TGF-β activates SMAD-2/3
signaling during RSV infection of macrophages; (c) TGF-β and
SMAD-2/3 signaling have any role in RSV infected macrophages;
and (d) TGF-β and SMAD-2/3 signaling regulate antiviral
signaling during RSV infection.
In the current study we have characterized the role of TGF-β
and SMAD-2/3 signaling during RSV infection of macrophages.
RSV triggered TGF-β production from macrophages, which
resulted in activation of SMAD-2/3 signaling pathway.
FIGURE 1 | RSV triggers TGF-β production and activates SMAD-2/3 signaling in macrophages. (A) Primary bone marrow derived macrophages (BMDMs)
and (B) mouse macrophage cell line RAW 264.7 were infected with RSV (1MOI) for different time points. Following infection, the medium supernatant was collected to
assess active TGF-β secretion by ELISA analysis. (C) BMDMs and (D) RAW 264.7 cells were infected with RSV (1MOI) for 2 and 4 h. Cell lysates were subjected to
western blot analysis with phospho-SMAD2 (p-SMAD2), SMAD2, and β-actin antibodies. The ELISA values (A,B) represent the mean ± standard deviation. *p, **p,
and ***p ≤ 0.05 using a Student’s t-test.
Surprisingly, induction of autophagy was required for SMAD-
2/3 signaling during RSV infection. Furthermore, TGF-β and
SMAD-2/3 signaling regulated antiviral response during RSV
infection of macrophages since interferon-β (IFN-β) production
was significantly reduced in cells lacking TGF-β dependent
SMAD-2/3 signaling. Thus, our studies have demonstrated a
role of autophagy—TGF-β—SMAD2/3 signaling network in
positively regulating antiviral response (i.e., IFN-β production)
during RSV infection.
RESULTS
RSV Triggers TGF-β Production and
Activates SMAD-2/3 Signaling in
Macrophages
RSV infection results in TGF-β production from non-myeloid
cells like lung epithelial cells (McCann and Imani, 2007; Gibbs
et al., 2009; Mgbemena et al., 2011; Bakre et al., 2015). However,
it is still unknown whether TGF-β is released from RSV infected
myeloid cells like macrophages. Therefore, we investigated TGF-
β production from RSV infected macrophages. For these studies,
we infected primary mouse bone marrow derived macrophages
(BMDMs) and mouse macrophage RAW 264.7 cell-line with
RSV. At 2, 4, and 8 h post-infection, medium supernatant was
collected to analyze active TGF-β levels by ELISA. RSV infection
triggered TGF-β release from macrophages, since we detected
TGF-β in the medium supernatant of RSV infected BMDMs
and RAW 264.7 cells (Figures 1A,B). TGF-β production was
independent of cell toxicity or cell death since we failed to detect
LDH (LDH cytotoxicity assay), apoptosis and necrosis during the
2–8 h post-RSV infection (data not shown).
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TGF-β activates SMAD-2/3 signaling pathway following
binding to TGF-β receptor (TGF-βR) (Heldin and Moustakas,
2016). Although TGF-β production from RSV infected lung
epithelial cells has been noted earlier (McCann and Imani, 2007;
Gibbs et al., 2009; Mgbemena et al., 2011; Brubaker et al.,
2015), it is still unknown whether RSV activates SMAD-2/3
signaling pathway. In order to investigate the status of SMAD-2/3
signaling during RSV infection, BMDMs, and RAW 264.7 cells
were infected with RSV. Cell lysate derived from infected cells
were subjected to Western blot analysis to detect phosphorylated
form of SMAD-2 (phospho-SMAD2). SMAD-2 phosphorylation
only occurs following TGF-β/TGF-βR mediated activation of
SMAD-2/3 signaling. RSV infection resulted in activation of
SMAD-2/3 signaling in macrophages. Phospho-SMAD2 was
detected in RSV infectedmacrophages (Figures 1C,D). Thus, our
study shows TGF-β production from RSV infected macrophages
and subsequent activation of SMAD-2/3 signaling pathway in
infected cells.
Autophagy Induction during RSV Infection
Promotes TGF-β Production and SMAD-2/3
Signaling Pathway Activation
Although TGF-β is released from RSV infected epithelial cells
(McCann and Imani, 2007; Gibbs et al., 2009; Mgbemena et al.,
2011; Bakre et al., 2015), the mechanism triggering TGF-β
production during infection is still unknown. Since RSV induces
autophagy (Morris et al., 2011; Reed et al., 2013; Owczarczyk
et al., 2015), we next examined a possible role of autophagy in
positively regulating TGF-β production during RSV infection.
RSV induced autophagy in macrophages was deduced from
Western blotting with LC3 antibody (Figures 2A,B). In order to
assess autophagy’s role, we treated cells with autophagy inhibitor
3 MA. Autophagy plays an important role in TGF-β production
during RSV infection, since 3 MA treatment abrogated TGF-
β release from RSV infected BMDMs (Figure 2C). A similar
result was observed following treatment of RSV infected RAW
264.7 cells with 3 MA (data not shown). Autophagy was also
required for activation of SMAD-2/3 signaling during RSV
infection. Western blot analysis revealed drastic reduction in
phospho-SMAD2 levels following treatment of RSV infected
BMDMs with 3 MA (Figure 2D). A similar result was observed
in 3 MA treated RAW 264.7 cells infected with RSV (data not
shown).
To further validate our results we generated macrophages
deficient in beclin-1, a critical cellular factor required for
autophagy induction. Beclin-1 silencing by siRNA led to loss of
beclin-1 protein expression in BMDMs (Figure 3A) and RAW
264.7 (Figure 3B) cells. In accordance with our studies with 3
MA, we observed loss of phospho-SMAD2 protein following
RSV infection of beclin-1 deficient BMDMs (Figure 3C) and
RAW 264.7 (Figure 3D) macrophages. Thus, we have identified
autophagy as one of the major cellular events triggering TGF-β
production and SMAD-2/3 signaling pathway activation during
RSV infection.
FIGURE 2 | Autophagy induction during RSV infection promotes TGF-β production and SMAD-2/3 signaling pathway activation. (A) BMDMs were
infected with RSV (1MOI) for 1, 2, and 4 h. Cell lysates from mock and RSV infected cells were subjected to western blotting with LC3 antibody. (B) Band intensity of
LC3-I and LC3-II (Figure 2A) was quantified and the ratio of LC3-II/LC3-I was plotted to denote autophagy induction during RSV infection. (C) BMDMs were
pre-treated with autophagy inhibitor (3 MA; 5 mM) for 2 h and infected with RSV (1MOI) in presence of DMSO (vehicle control) or 3 MA. Following infection, TGF-β
levels in the medium supernatant was measured by ELISA. (D) BMDMs were pre-treated with 3 MA (5 mM) for 2 h and infected with RSV (1MOI) in presence of DMSO
or 3 MA. Cell lysates were subjected to western blot analysis with phospho-SMAD2 (p-SMAD2), SMAD2, and β-actin antibodies. The ELISA value (C) represents the
mean ± standard deviation. *p ≤ 0.05 using a Student’s t-test.
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FIGURE 3 | Autophagy induction during RSV infection promotes
SMAD-2/3 signaling pathway activation. BMDMs (A) and RAW 264.7 cells
(B) were transfected with either control siRNA or beclin-1 siRNA (60 pmol). Cell
lysates collected from these cells were subjected to western blot analysis with
beclin-1 and β-actin antibodies. RAW 264.7 cells (C) and BMDMs (D) cells
silenced for beclin-1 expression were infected with RSV. Cell lysate collected
from these cells were subjected to western blot analysis with phospho-SMAD2
(p-SMAD2), SMAD2, and β-actin antibodies. NT; non-transfected cells.
TGF-β and SMAD-2/3 Signaling is Required
for Optimal Interferon-β (IFN-β) Production
during RSV Infection
Previous studies with lung epithelial cells revealed a role of TGF-
β in modulating RSV infection (McCann and Imani, 2007; Gibbs
et al., 2009; Mgbemena et al., 2011; Bakre et al., 2015), since
blocking TGF-β activity reduced RSV infection of lung epithelial
cells (McCann and Imani, 2007; Gibbs et al., 2009; Mgbemena
et al., 2011). In that context, the exact role of TGF-β during RSV
infection is still unknown. Moreover, studies exploring the role of
SMAD-2/3 signaling during RSV infection are lacking.
RSV infection of macrophages is abortive (Segovia et al.,
2012). Cellular entry and replication of RSV has been
documented in macrophages. However, infectious RSV progeny
virus is not released (virus budding) from macrophages.
Although macrophages do not support RSV budding, RSV
infected macrophages produce high level of IFN-β. It is now
becoming apparent that type I interferon (IFN-α/β) released
from RSV infected myeloid cells like macrophages are critical
for airway host defense against RSV. Interestingly, TGF-β and
SMAD-2/3 signaling can positively regulate type-I interferon
production and response (Qing et al., 2004). In light of the
role of TGF-β and SMAD-2/3 signaling in modulating IFN-
β response, we next investigated whether TGF-β—SMAD2/3
pathway regulates IFN-β production during RSV infection.
For these studies we utilized the TGF-β inhibitor SB-431542,
that blocks extracellular TGF-β activity by inhibiting TGF-β
binding to TGF-β receptor. In addition, we utilized SMAD-2
deficient macrophages to study the role of SMAD-2/3 signaling
during IFN-β response. TGF-β was required for optimal IFN-
β response during RSV infection since significant reduction in
IFN-β production was observed following treatment of RSV
infected BMDMs (Figure 4A) and RAW 264.7 (Figure 4B) cells
with SB-431542. SB-431542 treatment also drastically abrogated
IFN-β expression in RSV infected macrophages (Figure 4C).
These results were further validated by using SMAD-2 deficient
macrophages. We used siRNA to silence SMAD-2 expression
in RAW 264.7 cells. Reduced SMAD-2 protein expression was
noted in cells transfected with SMAD-2 siRNA (Figure 4D). RSV
infection of SMAD-2 deficient cells resulted in significant loss
of IFN-β production (Figure 4E). These results have highlighted
a mechanism of IFN-β production during RSV infection. Our
study suggests a role of TGF-β induced SMAD-2/3 signaling
pathway in promoting activation of antiviral response by virtue of
facilitating production of IFN-β fromRSV infectedmacrophages.
These studies have also illustrated a biological role of TGF-β and
SMAD-2/3 signaling in positively regulating antiviral response in
macrophages during RSV infection.
The role of TGF-β and SMAD-2/3 signaling in positively
regulating IFN-β production was validated by investigating RSV
infection in macrophages. IFN-β mediated antiviral response
restricts RSV replication and therefore, loss of IFN-β production
results in enhanced viral replication. Since RSV does not
productively infect macrophages, we did not perform plaque
assay analysis with medium supernatant of RSV infected
macrophages. Instead, we analyzed RSV replication by evaluating
expression of RSV nucleocapsid (N) protein mRNA. Indeed
diminished IFN-β production from TGF-β signaling inhibited
cells led to enhanced RSV replication since elevated expression
of RSV N mRNA was observed in cells silenced for SMAD2
expression (Figures 5A,B). Similar enhanced expression of RSV
fusion (F) protein was noted following Western blot analysis
(with RSV F protein antibody) of RSV infected cell lysate derived
from macrophages treated with TGF-β inhibitor SB-431542
(data not shown). A temporal relationship of TGF-β and IFN-
β production during RSV infection was also evident. Although
we detected TGF-β production from RSV infected macrophages
at 2 h post-infection (Figures 1A,B), we failed to detect IFN-
β at 2 h post-infection (Figure 5C). However, IFN-β could be
detected at 4 h post-RSV infection (Figure 5C). This result
demonstrated TGF-β production preceding IFN-β production
during RSV infection and therefore this temporal event suggested
TGF-β mediated regulation of IFN-β production.
Autophagy Regulates IFN-β Production
from RSV Infected Macrophages
Autophagy triggered TGF-β—SMAD2/3 signaling, which
was involved in IFN-β production during RSV infection of
macrophages. These results suggested a role of autophagy in
IFN-β production from infected macrophages. Interestingly,
autophagy induction was required for optimal IFN-β production
from RSV infected dendritic cells (DCs) and mouse airway
(Morris et al., 2011; Reed et al., 2013; Owczarczyk et al., 2015).
However, autophagy induction has not been studied yet in RSV
infected macrophages. RSV infection led to autophagy induction
in primary BMDMs (Figures 2A,B) and macrophage cell-line
RAW 264.7 cells (data not shown). Role of autophagy was next
evaluated by analyzing IFN-β production from macrophages
treated with autophagy inhibitor 3 MA. Autophagy induction
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FIGURE 4 | TGF-β and SMAD-2/3 signaling is required for optimal interferon-β (IFN-β) production during RSV infection. BMDMs (A) and RAW 264.7 cells
(B) treated with either DMSO (vehicle control) or TGF-β inhibitor (SB-431542; 10 µM) were infected with RSV (1MOI; 16 h). Following infection, medium supernatant
was assessed for IFN-β secretion by ELISA analysis. (C) RAW264.7 cells treated with either DMSO or SB-431542 (SB) were infected with RSV (1MOI). At 16 h
post-infection, RT-PCR analysis was performed to assess IFN-β expression. (D) RAW 264.7 cells were transfected with either control siRNA or SMAD2 siRNA. Cell
lysates collected from these cells were subjected to western blot analysis with SMAD2 and β-actin antibodies. (E) RAW 264.7 cells transfected with either control
siRNA or SMAD2 siRNA were infected with RSV (1MOI). At 16 h post-infection, medium supernatant was collected to assess IFN-β level by ELISA. The ELISA values
(A,B,E) represent the mean ± standard deviation. *p ≤ 0.05 using a Student’s t-test. NT; non-transfected cells.
FIGURE 5 | TGF-β regulates RSV replication in macrophages and IFN-β
production kinetics following RSV infection. (A) RAW 264.7 cells
transfected with either control siRNA or SMAD2 siRNA were infected with RSV
(1MOI). At 16 h post-infection, RT-PCR analysis was performed to assess
expression RSV nucleocapsid (N) protein mRNA. (B) Band intensity of RSV N
and GAPDH in control siRNA and SMAD2 siRNA transfected cells (Figure 5A)
was quantified and the ratio of N/GAPDH was plotted to denote enhanced
expression of RSV N in SMAD2 siRNA transfected cells. (C) RAW 264.7 were
infected with RSV (1MOI) for 0 h (mock), 2, 4, and 8 h. Following infection, the
medium supernatant was collected to assess IFN-β production by ELISA
analysis. The ELISA value represents the mean ± standard deviation. *p and
**p ≤ 0.05 using a Student’s t-test.
in macrophages during RSV infection was required for IFN-β
production since 3 MA treatment drastically reduced IFN-β
release from RSV infected BMDMs (Figure 6A) and RAW 264.7
(Figure 6B) macrophages. Concomitantly, RSV failed to induce
IFN-β expression in 3 MA treated macrophages (Figure 6C).
This result was further validated by using autophagy deficient
RAW 264.7 cells that are silenced for beclin-1 expression
(Figure 3B). RSV infection of beclin-1 deficient macrophages
led to drastic reduction in IFN-β expression (Figure 6D).
Loss of IFN-β production from autophagy inhibited cells led
to enhanced RSV replication since elevated RSV F protein
expression was observed in cells treated with autophagy inhibitor
3 MA (Figures 6E,F). These results have demonstrated a critical
role of autophagy in triggering antiviral response in RSV infected
macrophages by promoting IFN-β release.
DISCUSSION
Based on our study, we postulate a scheme (and a model) of IFN-
β production from RSV infected macrophages (Figure 7). RSV
infected macrophages will induce autophagy, which will trigger
TGF-β release. Cell surface TGF-β receptor is then activated
by extracellular TGF-β via paracrine/autocrine action. This will
culminate in activation (i.e., phosphorylation of SMAD-2/3) of
SMAD-2/3 pathway and subsequent expression/production of
IFN-β. Thus, our studies have illustrated an important role
of autophagy— TGF-β—SMAD2/3 pathway in launching an
antiviral response (i.e., IFN-β production) in RSV infected
macrophages.
TGF-β is a pleotropic cytokine regulating a plethora
of biological functions and activities, including immune
surveillance, pro-, and anti-inflammatory response, and cell-
cycle regulation (Travis and Sheppard, 2014; Heldin and
Moustakas, 2016). Respiratory RNA viruses like influenza A
virus (IAV), RSV and rhinovirus triggers TGF-β expression
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FIGURE 6 | Autophagy regulates IFN-β production from RSV infected macrophages. BMDMs (A) and RAW 264.7 cells (B) treated with either DMSO (vehicle
control) or autophagy inhibitor (3 MA; 5 mM) were infected with RSV (1MOI). At 16 h post-RSV infection, medium supernatant was collected to assess IFN-β
production by ELISA. (C) RAW 264.7 cells treated with either DMSO or 3 MA were infected with RSV (1MOI). At 16 h post-infection, RT-PCR analysis was performed
to analyze IFN-β expression. (D) RAW 264.7 cells transfected with either control siRNA or beclin-1 siRNA were infected with RSV (1MOI). At 16 h post-infection,
RT-PCR analysis was performed to analyze IFN-β expression. (E) RAW 264.7 cells treated with either DMSO (vehicle control) or autophagy inhibitor (3 MA; 5 mM)
were infected with RSV (1MOI). At 16 h post-RSV infection, cell lysate was subjected to Western blot analysis with RSV fusion (F) protein antibody. (F) Band intensity
of RSV F and actin in DMSO and 3 MA treated cells (Figure 6E) was quantified and the ratio of F protein/actin was plotted to denote enhanced expression of RSV F
protein in 3 MA treated cells. The ELISA values (A,B) represent the mean ± standard deviation. *p ≤ 0.05 using a Student’s t-test.
FIGURE 7 | A model depicting the role of
autophagy—TGF-β—SMAD2/3 signaling network in positively
regulating IFN-β production during RSV infection of macrophages. RSV
infection triggers autophagy in macrophages and this event promotes TGF-β
production. Cell surface TGF-β receptor (TGFR) is then activated by
extracellular TGF-β via paracrine/autocrine action. Interaction of extracellular
TGF-β with TGFR will result in activation of SMAD-2/3 signaling comprising of
phosphorylation of SMAD-2/3. Activation (i.e., phosphorylation of SMAD-2/3)
of SMAD-2/3 will result in IFN-β expression and production.
and release from non-myeloid cells like lung epithelial cells
and fibroblasts (Thomas et al., 2009; Bedke et al., 2012;
Li et al., 2015). Surprisingly, we and others have shown a
presumptive detrimental role of TGF-β in host defense against
respiratory RNA viruses. TGF-β facilitated RSV (McCann and
Imani, 2007; Gibbs et al., 2009; Mgbemena et al., 2011) and
rhinovirus (Thomas et al., 2009; Bedke et al., 2012) infection of
lung epithelial cells and airway fibroblasts. Accordingly, TGF-β
diminished antiviral response by reducing type-I IFN production
from rhinovirus infected fibroblasts and epithelial cells (Thomas
et al., 2009; Bedke et al., 2012). An interesting aspect of TGF-β
is its cell-type dependent response. Particularly, TGF-β activity
(and response) may profoundly differ in myeloid vs. non-
myeloid cells. In that context, there is only one study showing
a respiratory virus (RSV) up-regulating TGF-β in a myeloid
cell (cord blood DCs) and studies with DC-T cell co-culture
(RSV infected DC co-cultured with T-cells) revealed a role of
TGF-β in modulating in vitro T-cell response (Thornburg et al.,
2010). Due to limited studies with myeloid cells, particularly with
no studies being performed with macrophages, we investigated
whether—(a) RSV triggers TGF-β release from macrophages;
and (b) TGF-β produced from RSV infected macrophages plays
any functional role in regulating innate immune response.
Our studies have demonstrated that—(a) TGF-β is released
from RSV infected macrophages; and (b) TGF-β—SMAD2/3
signaling is required for optimal IFN-β production during RSV
infection.
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SMAD-2/3 pathway represents the major TGF-β signaling
cascade responsible for transmitting intracellular response
originating on the cell surface following interaction of TGF-
β with type-II TGF-β receptor (Heldin and Moustakas, 2016).
So far no studies have focused on the SMAD-2/3 pathway
during respiratory virus infection. It is unknown whether—(a)
respiratory viruses like RSV activates SMAD-2/3 pathway; and
(b) SMAD-2/3 pathway play any role in regulating virus infection
and innate immune response. Our study revealed—(a) activation
of SMAD-2/3 pathway in RSV infected macrophages; and (b)
a role of SMAD-2/3 pathway in triggering IFN-β production
during RSV infection and thus, “positively” regulating innate
antiviral response.
Interferon regulatory factors (IRFs like IRF3, IRF7) play
pivotal role in antiviral response (Stark et al., 1998; Honda
et al., 2005; Ciancanelli et al., 2015). IRF3 and IRF7 are
transcription factors residing in the cytoplasm of resting cells.
They are activated (phosphorylated) by upstream signaling
cascade originating from activated PRRs like toll-like receptors
(TLRs) (Uematsu and Akira, 2007; Wilkins and Gale, 2010;
Newton and Dixit, 2012). Activated IRF3 and IRF7 translocate
to the nucleus to transactivate IFN-α and IFN-β gene expression.
TLR3 activation in macrophages during RSV infection (Tsai
et al., 2015) culminates in IFN-β expression/production, by virtue
of IRF3 and IRF7 activation (Casola et al., 2001; Jewell et al.,
2007; Sabbah et al., 2009; Remot et al., 2016). In that regard,
IRF7 is required for IFN-β gene expression following TLR3
activation (Siednienko et al., 2012). Interestingly, TGF-β and
SMAD-2/3 signaling plays an important role in up-regulating
IRF7 transcriptional activity (Qing et al., 2004). Mechanistically,
IRF7 is complexed with activated SMAD-3 and this complex
upon translocation to the nucleus co-operatively acts on the
ISRE (Interferon Stimulated Response Element) to optimally
express IFN-β gene. TGF-β signaling blockade diminished IRF7
dependent IFN-β expression and release. IRF7 is a virus specific
IFN-β inducer operating during MyD88-independent TLR
signaling (e.g., TLR3 signaling) (Honda et al., 2005). RSV induces
IRF7 expression in cells and mice respiratory tract (Casola et al.,
2001; Jewell et al., 2007; Remot et al., 2016). Furthermore, IRF7 is
constitutively expressed (and induced following virus infection)
in primary macrophages and macrophage cell-lines like RAW
264.7 cells (Wilden et al., 2009; Ning et al., 2011). In that scenario,
we envision TGF-β released from RSV infected macrophages will
activate cell surface TGF-β receptor. Subsequent activation of
SMAD-2 and SMAD-3 will lead to translocation of SMAD-IRF7
complex to the nucleus to transactivate IFN-β gene expression.
In the future we will conduct studies to elucidate the mechanism
regulating TGF-β expression and release during RSV infection.
Furthermore, we will investigate the role of IRF7 and SMAD-
IRF7 complex in regulating IFN-β expression during RSV
infection of macrophages.
Autophagy constitutes a critical cellular process that
maintains cellular homeostasis for normal biological and
physiological functions (Shibutani et al., 2015). RSV induces
autophagy in dendritic cells (DCs) and in the respiratory
tract of infected mice (Morris et al., 2011; Reed et al., 2013;
Owczarczyk et al., 2015). Autophagy is required for efficient
IFN-β response during RSV infection, since lack of autophagy
reduces IFN-β release from RSV infected DCs. Although
RSV induced autophagy in DCs, autophagy induction in RSV
infected macrophages has not been reported yet. We now
show autophagy induction in RSV infected macrophages.
Furthermore, our studies have illustrated a functional role of
autophagy in positively regulating antiviral response (IFN-β
production) in macrophages infected with RSV. Given the fact
that TLR3 induces autophagy in macrophages (Delgado et al.,
2008) and TLR3 is activated by RSV in these cells (Tsai et al.,
2015), we postulate that autophagy induction in RSV infected
macrophages occur due to RSV mediated activation of TLR3
pathway. A relationship between autophagy and TLR3 is evident
from strikingly similar lung cytokine profile and pathogenesis
severity in RSV infected autophagy deficient (i.e., beclin-1
deficient mice) and TLR3 knockout mice (Reed et al., 2013). In
addition to TLR3, it is plausible that ssRNA genome of RSV can
induce autophagy following TLR7 activation. TLR7 activation
results in autophagy induction (Sanjuan et al., 2007; Delgado
et al., 2008) and thus, during early infection ssRNA originating
from RSV can induce autophagy via TLR7.
In summary, our studies have resulted in identification
of autophagy—TGF-β–SMAD2/3 signaling network in
macrophages as a critical cellular event required for optimal
antiviral response (IFN-β production) following RSV infection.
MATERIALS AND METHODS
Virus and Cell Culture
Human respiratory syncytial virus (RSV A2 strain) was
propagated in CV-1 cells and purified by centrifuging two
times on discontinuous sucrose gradients as described previously
(Segovia et al., 2012; Tsai et al., 2015). C57BL/6J mice were
obtained from Jackson Laboratory. Bone marrow derived
macrophages (BMDMs) were derived from femur and tibia
of wild type (WT) mice and were cultured for 6–8 days
as described earlier (Segovia et al., 2012; Tsai et al., 2014,
2015). Unless otherwise stated, BMDMs were plated on 12
well plates containing Roswell Park Memorial Institute medium
1640 (RPMI) (Gibco), 10% FBS (Gibco), 100 IU/mL penicillin,
100 mg/mL streptomycin (Gibco), and 20 ng/ml GM-CSF
(Peprotech). RAW264.7 (mouse macrophage cell line) cells
obtained from ATCC were maintained in Dulbecco’s modified
Eagle medium (DMEM), 10% FBS, 100 IU/mL penicillin, 100
mg/mL streptomycin unless otherwise noted.
Animal studies were performed according to housing and
care of laboratory animals guidelines established by National
Institutes for Health (NIH). All animal experiments were
reviewed and approved by the Institutional Animal Care and Use
Committee (IACUC) of Washington State University.
Viral Infection of Cells
BMDMs and RAW264.7 cells were infected with purified RSV at
one multiplicity of infection (MOI) in serum free antibiotic free
OPTI-MEM medium (Gibco). Virus adsorption was performed
for 1.5 h at 37◦C. Following adsorption, cells were washed twice
with DPBS (Dulbecco’s phosphate-buffered saline) (Gibco) and
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the infection was continued in presence or absence of serum
containing medium. To examine TGF-β secretion and SMAD-2
phosphorylation during RSV infection, BMDMs, and RAW264.7
cells were cultured in serum free medium.
In some experiments, cells were pre-treated with 3-
methyladenine (3 MA; Sigma Aldrich) or TGF-β inhibitor
(SB-431542; InVivogen). After pre-treatment, cells were infected
with RSV and infection was continued in presence or absence
of respective inhibitors. Dimethyl sulfoxide (DMSO) served as a
vehicle control for SB-431542 and 3 MA.
siRNA Transfection
Mouse beclin-1 and mouse SMAD-2 were silenced in BMDMs
or RAW 264.7 cells by using Lipofectamine 2000 for 24–48
h. Control siRNA, mouse beclin-1 siRNA and mouse SMAD-
2 siRNA were purchased from Santa Cruz Biotechnology. Cells
were transfected with 60 pmol of siRNAs.
ELISA Assay
Medium supernatants collected from RAW 264.7 cells and
BMDMs were analyzed for active TGF-β (ebioscience) and IFN-β
(PBL Assay Science) levels by cytokine-specific ELISA kit.
RNA Isolation and Reverse
Transcriptase-PCR (RT-PCR)
Total RNA was extracted using TRIzol reagent (Life
Technologies) following supplier’s instructions. RT-PCR
analysis was performed as described previously (Tsai et al., 2014,
2015; Segovia et al., 2015). MultiScribe reverse transcriptase
(Applied Biosystem) was used to synthesize template cDNA.
PCR was performed using 2X Taq Red master mix (Apex) in
final reaction of 25 µl. The amplification cycle was as follows: an
initial denaturing step (95◦C for 5 min) was followed by 28–30
cycles of denaturing (95◦C for 30 s), annealing (55–60◦C for 30
s–1 min), and extending (72◦C for 30 s), followed by either 5
or 10 min at 72◦C for elongation. Following amplification, the
PCR products were analyzed on 1% agarose gels and bands were
visualized by ChemiDoc XRS (BioRad). Housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used
as a loading control. The primers used to detect the indicated
gene are listed below:
Mouse GAPDH forward, (5′GCCAAGGTCATCCATGACA
ACTTTGG-3′) and mouse GAPDH reverse, (5′GCCTGCT
TCACCACCTTCTTGATGTC-3′)
Mouse IFN-β forward, (5′-CAGCTCCAGCTCCAAGAAAGG
ACGAACATTCG-3′) and mouse IFN-β reverse, (5′-CCACCA
CTCATTCTGAGGCATCAACTGACAGG-3′)
RSV-N forward, (5′-GGAACAAGTTGTTGAGGTTTATGAA
TATGC-3′) and
RSV-N reverse, (5′-TTCTGCTGTCAAGTCTAGTACACTGT
AGT-3′)
For some experiments, the PCR product bands were quantified
using Image Lab Software (Bio-Rad).
Western Blotting
BMDMs and RAW264.7 cells were lysed using 1%-Triton X-100
in PBS (pH 7.4), EDTA-free protease inhibitor cocktail (Roche
Diagnostics) and 10 mM of sodium pyrophosphate (Sigma)
in PBS. Cell lysates were subjected to 10–15% SDS-PAGE.
Separated proteins were transferred onto 0.2 µm nitrocellulose
membrane (GE Health care) and blotted with specific antibodies.
SMAD-2, phospho-SMAD2 and LC-3 antibodies were purchased
from Cell signaling. Beclin-1 antibody was purchased from
Abcam. RSV fusion (F) protein antibody was obtained from
FDA (Dr. Judy Beeler). β-actin antibody was purchased from
Bethyl Laboratories. For some experiments, protein bands from
Western blot were quantified using Image Lab Software (Bio-
Rad).
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